Zobrazeno 1 - 10
of 309
pro vyhledávání: '"W Schlake"'
Autor:
Lina Philipp, W. Schlake, Gudrun Schlake, Christoph Petry, Anja Neumann, Ralf Kronenwett, Silke Neusser, Peter Tönnies, Jürgen Wasem, Janine Biermann-Stallwitz, Stefan Wilhelms
Publikováno v:
Journal of Public Health. 29:1021-1027
The objective of this article is the economic evaluation of the EndoPredict test in the assessment of the indication for chemotherapy in female breast cancer patients with intermediate risk of recurrence. A retrospective cost analysis based on patien
Autor:
Bryan W. Schlake, Xiang Liu
Publikováno v:
Transportation Research Part C: Emerging Technologies. 72:77-92
Liquefied natural gas (LNG) has emerged as a possible alternative fuel for freight railroads in the United States, due to the availability of cheap domestic natural gas and continued pursuit of environmental and energy sustainability. A safety concer
Publikováno v:
2018 Joint Rail Conference.
Freight railroad classification yards have been compared to large-scale manufacturing plants, with inbound trains as the inputs and outbound trains as the outputs. Railcars often take up to 24 hours to be processed through a railyard due to the need
Publikováno v:
Der Pathologe. 36:615-618
Autor:
Manfred Dietel, Andreas Jung, W. Schlake, Matthias Kloor, Hans Kreipe, S.T. Liffers, K.L. Schäfer, Peter Schirmacher, Gustavo B. Baretton, Christine Sers, T. Kirchner, H.E. Gabbert
Publikováno v:
Der Onkologe. 20:492-496
Die wichtigsten, fur das metastasierte kolorektale Karzinom (mKRK) bislang zugelassenen zielgerichteten Substanzen sind Cetuximab (Erbitux®) und Panitumumab (Vectibix®), beides Antikorper gegen den „epidermal growth factor receptor“ (EGFR oder
Autor:
L Philipp, W Schlake, Silke Neusser, R Kronenwett, P Tönnies, C Petry, S Wilhelms, Juergen Wasem, Janine Biermann, G Schlake, F Tiecke
Publikováno v:
16. Deutscher Kongress für Versorgungsforschung (DKVF); 20171004-20171006; Berlin; DOCP060 /20170926/
Hintergrund: Brustkrebs ist die häufigste onkologische Erkrankung bei Frauen weltweit mit einer Inzidenz von etwa 1,67 Millionen neuen Fällen pro Jahr. In Deutschland werden jährlich 70.000 neue Fälle diagnostiziert. Zielgruppe des EndoPredict-Te
Autor:
Alexander Ricci, Bryan W. Schlake
Publikováno v:
2016 Joint Rail Conference.
As railroads and local industries served by rail seek to reduce emissions and improve fuel efficiency, new technologies are being developed to serve this market. Contrary to the minimal competitive options available over the last several decades, new
Autor:
Reinhard Büttner, S. Merkelbach-Bruse, H.H. Kreipe, Manfred Dietel, Roland Penzel, Josef Rüschoff, Alexander Enk, Rudolf Stadler, Annika Lehmann, W. Schlake, Claus Garbe, T. Kirchner, Peter Schirmacher, Andreas Jung, Jürgen Bauer, U. Kellner
Publikováno v:
Der Pathologe. 33:352-356
Autor:
Dontscho Kerjaschki, Bruno Valentin Sinn, Judith Prinzler, Gudrun Schlake, Zsuzsanna Bago-Horvath, Margaretha Rudas, W. Schlake, Karsten Weber, Heinz Höfler, Carsten Denkert, Ulrich Lehmann, Markus Schmidt, Manfred Dietel, Kerstin Bohmann, Peter Schraml, Frank Tiecke, Katja Specht, H.H. Kreipe, Christoph Petry, Roland Penzel, Martin Filipits, H Moch, Ralf Kronenwett, Peter Schirmacher
Publikováno v:
Senologie - Zeitschrift für Mammadiagnostik und -therapie. 8:6-9
Autor:
Zsuzsanna Bago-Horvath, Ralf Kronenwett, Katja Specht, Ulrich Lehmann, Peter Schraml, Gudrun Schlake, Bruno Valentin Sinn, Holger Moch, Peter Schirmacher, W. Schlake, Berit Maria Müller, Zsuzsanna Varga, Hans Kreipe, Martin Filipits, Carsten Denkert, Judith Prinzler, Manfred Dietel, Christoph Petry, Marcus Schmidt, Karsten Weber, Roland Penzel, Dontscho Kerjaschki, Frank Tiecke, Kerstin Bohmann, Margaretha Rudas, Heinz Höfler
Publikováno v:
Virchows Archiv
Gene expression profiles provide important information about the biology of breast tumors and can be used to develop prognostic tests. However, the implementation of quantitative RNA-based testing in routine molecular pathology has not been accomplis